Efficacy of nab-paclitaxel does not seem to be associated with SPARC expression in metastatic breast cancer. [electronic resource]
Producer: 20150109Description: 6609-15 p. digitalISSN:- 1791-7530
- Adult
- Aged
- Albumins -- administration & dosage
- Biomarkers, Tumor -- metabolism
- Breast Neoplasms -- drug therapy
- Dose-Response Relationship, Drug
- Enzyme-Linked Immunosorbent Assay
- Female
- Follow-Up Studies
- Humans
- Immunoenzyme Techniques
- Middle Aged
- Neoplasm Metastasis
- Neoplasm Staging
- Osteonectin -- metabolism
- Paclitaxel -- administration & dosage
- Prognosis
- Prospective Studies
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.